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Folate derivatives are essential vitamins for cell growth and
replication, primarily because of their central role in reactions
of one-carbon metabolism. Folates require polyglutamation to
be efﬁciently retained within the cell and folate-dependent
enzymes have a higher afﬁnity for the polyglutamylated forms
of this cofactor. Polyglutamylation is dependent on the
enzyme folylpolyglutamate synthetase (FPGS), which cata-
lyzes the sequential addition of several glutamates to folate.
FPGS is essential for the growth and survival of important
bacterial species, including Mycobacterium tuberculosis, and is
a potential drug target. Here, the crystal structures of
M. tuberculosis FPGS in complex with ADP and AMPPCP
are reported at 2.0 and 2.3 A ˚ resolution, respectively. The
structures reveal a deeply buried nucleotide-binding site, as in
the Escherichia coli and Lactobacillus casei FPGS structures,
and a long extended groove for the binding of folate
substrates. Differences from the E. coli and L. casei FPGS
structures are seen in the binding of a key divalent cation, the
carbamylation state of an essential lysine side chain and the
adoption of an ‘open’ position by the active-site  5– 6 loop.
These changes point to coordinated events that are associated
with dihydropteroate/folate binding and the catalysis of the
new amide bond with an incoming glutamate residue.
Received 20 February 2008
Accepted 28 April 2008
PDB References: MtFPGS–
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1. Introduction
Folic acid and its derivatives are essential vitamins that are
required for cell growth and replication in both prokaryotic
and eukaryotic cells. Folic acid serves as a carrier of single-
carbon units, typically in the form of methyl and formyl
substituents at the N-5 and N-10 positions or as bridging N-5/
N-10 methylene groups (Fig. 1). These folate derivatives are
essential for a number of diverse biochemical pathways,
including methionine metabolism, the biosynthesis of purine
nucleotides and thymidylate synthesis. Because most of the
reactions involving folate substrates result in the transfer of
single-carbon units, the reactions are collectively known as
one-carbon metabolism (Shane, 1989). Folate coenzymes are
of particular importance during pregnancy or infancy and
folate deﬁciency can manifest itself in several ways including
placenta-mediated diseases (Ray & Laskin, 1999), neural tube
defects in newborns (Pitkin, 2007), hyperhomocysteinaemia
(Bailey, 1995; Durand et al., 1998) and the development of
some cancers (Kim, 1999).
Folates within the cell are generally found as polyglutamate
derivatives. Since the presence of the long negatively charged
tail effectively prevents efﬂux through the cell membrane, it
was initially thought that polyglutamylation was simply a way
of storing folate and raising the cellular concentration (Shane,1989). However, it has since been shown that many folate-
dependent enzymes have a higher afﬁnity for its poly-
glutamylated forms (Lu et al., 1984; Lowe et al., 1993; Schirch
& Strong, 1989). Folate antagonists (so-called antifolates),
which have been used in cancer chemotherapy and as anti-
biotics, are also polyglutamylated, which can greatly enhance
their ability to inhibit certain enzymes (Synold et al., 1996).
In organisms that synthesize folates de novo (e.g. plants,
bacteria, fungi and protozoa), two enzymes catalyze the
addition of glutamic acid residues: dihydrofolate synthetase
(DHFS) adds the ﬁrst glutamic acid residue to dihyropteroate
(DHP) to produce dihydrofolate (DHF), after which the
ubiquitous enzyme folylpolyglutamate synthetase (FPGS; EC
6.3.2.17) catalyzes folate polyglutamylation. This occurs in all
cells, including those that require exogenous folate (e.g.
mammalian cells). In some bacteria, DHFS and FPGS activ-
ities reside on a single gene (e.g. Escherichia coli and
Corynebacterium), whereas in plants and fungi it appears that
distinct genes encode the two enzymes (Ravanel et al., 2001).
Both enzymes use a stepwise reaction in which glutamate
residues are added by the ATP-dependent formation of an
activated acyl-phosphate intermediate, followed by nucleo-
philic attack on the acyl phosphate by the incoming glutamate
molecule to produce the new amide bond (Fig. 1). The number
of glutamate residues added by FPGS appears to be species-
dependent; E. coli for example favors only three residues
(Osborne et al., 1993), whereas Lactobacillus casei can add up
to nine residues (Toy & Bognar, 1994).
Crystal structures of FPGS are available from three
bacterial species: L. casei (Sun et al., 1998, 2001; Sheng et al.,
2002; Smith et al., 2006), Thermotoga maritima (unpublished
work; PDB code 1o5z) and the bifunctional E. coli DHFS/
FPGS (Mathieu et al., 2005). In each case the enzyme
comprises two domains: an N-terminal ATPase domain and a
C-terminal Rossmann-fold domain, with the active site at the
interface between the two domains. The nucleotide-binding
site appears to be highly conserved in each case, but different
sites approximately 5 A ˚ apart have been found to bind pterin
substrates in the L. casei and E. coli enzymes (Sun et al., 2001;
Mathieu et al., 2005). It has been suggested that the site
observed in E. coli DHFS/FPGS may be used to add the ﬁrst
one or two glutamate residues and the second site, observed in
L. casei FPGS, may be used to add subsequent residues as the
tail elongates (Tan & Carlson, 2005; Smith et al., 2006). How
the tail is moved through the active site so that the terminal
 -carboxylate is always presented to the ATP and where this
growing tail is accommodated in the enzyme structure are yet
to be determined, but it is clear that protein dynamics must
play a signiﬁcant part.
As the production of polyglutamylated folates in vivo is of
vital importance to all living systems, this emerging evidence
of a distinction between dihydropteroate (DHP) and tetra-
hydrofolate (THF) binding by bacterial FPGS suggests that it
may be possible to design inhibitors of bacterial DHFS activity
that do not inhibit FPGS activity in humans, thereby selec-
tively inhibiting folate metabolism in bacteria. FPGS in
Mycobacterium tuberculosis (MtFPGS) has been shown to be
an essential gene for the growth of M. tuberculosis (Sassetti et
al., 2003) and like E. coli FPGS is thought to exhibit both
DHFS and FPGS activities. This raises the possibility that the
development of inhibitors of MtFPGS could also provide
potential leads for chemotherapy against tuberculosis (TB).
Here, we report the structures of M. tuberculosis FPGS in
complex with ADP and AMPPCP at resolutions of 2.0 and
2.3 A ˚ , respectively, and demonstrate differences in loop
closure, divalent cation binding and the carbamylation of an
active-site lysine residue that relate to substrate binding and
the reaction mechanism.
2. Experimental procedures
2.1. Cloning, expression and protein purification
The cloning, expression and puriﬁcation of MtFPGS were
carried out as described previously (Young et al., 2006).
Brieﬂy, the open reading frame encoding MtFPGS (Rv2445)
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Figure 1
Schematic representation of the reactions catalyzed by (a) dihydrofolate
synthetase (DHFS) and (b) folylpolyglutamate synthetase (FPGS). In
both reactions the dihydropteroate or folate substrates have the same co-
substrates (ATP and l-glutamate) and the reaction mechanisms are
identical, involving (1) activation of the free carboxylate by ATP and (2)
nucleophilic attack on the resulting acyl-phosphate intermediate by
l-glutamate. The different forms of the one-carbon derivatives of
tetrahydrofolate are shown on the lower molecule: (i) 10-methyl, (ii)
5,10-methylene and (iii) 10-formyl.was PCR-ampliﬁed from M. tuberculosis genomic DNA and
cloned into a modiﬁed pET42a plasmid (Novagen), pET42a-
rTEV, to produce the expression plasmid GST-His6-MtFPGS.
Recombinant MtFPGS protein was expressed in BL21
( DE3) pGROELS chaperone strain cells which were ‘cold-
shocked’ before induction with IPTG at 293 K for 16 h.
Selenomethionine-labelled MtFPGS (SeMet-MtFPGS) was
produced using a modiﬁed protocol based on inhibition of
methionine biosynthesis, as previously described (Young et al.,
2006).
Bacteria expressing MtFPGS were lysed and recombinant
protein was puriﬁed from the clariﬁed soluble fraction by
IMAC as described previously (Young et al., 2006). Eluted
fractions containing the bulk of the recombinant protein were
pooled and dialyzed with a 1:20 ratio of His6-tagged rTEV
protease at 277 K for 16 h to cleave the afﬁnity tag from
MtFPGS. MtFPGS was separated from the rTEV-His6
protease and cleaved GST-His6 afﬁnity tag by passage through
a nickel-chelating column and then further puriﬁed by size-
exclusion chromatography. SeMet-MtFPGS was puriﬁed using
the same procedures as used for native MtFPGS.
2.2. Crystallization, data collection and structure solution
MtFPGS was crystallized by a batch method as described
previously (Young et al., 2006). Protein pre-incubated with
either 1.5 mM ADP or AMPPCP and 2 mM MgCl2 was mixed
with an equal volume of precipitant solution comprising
14%(w/v) PEG 8000, 30%(v/v)M P D ,1 0 m M CoCl2 and
50 mM sodium acetate pH 5.5 and crystals were grown under
parafﬁn oil. Crystals appeared after 16 h and grew to a
maximum size of 100 mm after 96 h. Before ﬂash-freezing in
liquid nitrogen, the crystals were soaked for 60 min in a 60:40
mix of cryoprotectant [crystallization buffer + 30%(v/v)
glycerol] and protein buffer. Crystals of SeMet-MtFPGS, pre-
incubated with 1.5 mM ADP and 2 mM MgCl2, were grown
using the same batch method as used for native protein.
Multiwavelength anomalous dispersion (MAD) diffraction
data were collected from a single crystal of SeMet-MtFPGS–
ADP on beamline BL9-1 at the SSRL. A total of 55 images
were collected with an oscillation range of 1  per image, 20 s
exposure per image and a crystal-to-detector distance of
240 mm. Diffraction data from native MtFPGS–AMPPCP
crystals were collected on BL9-2 at the SSRL. A total of 60
images were collected with an exposure time of 2 s and an
oscillation range of 1  per image.
All data were indexed and integrated with MOSFLM
(Leslie, 2006) and reduced with SCALA (Evans, 2006) from
the CCP4 suite (Potterton et al., 2003; Collaborative Compu-
tational Project, Number 4, 1994). Some data-collection
statistics are presented in Table 1. The crystals proved to be
cubic, space group P213, with unit-cell parameters
a = b = c = 112.4 A ˚ and one MtFPGS molecule in the asym-
metric unit, with an estimated solvent content of 46%
(Matthews, 1968). The structure of MtFPGS–ADP was
determined by SAD using autoSHARP (Vonrhein et al., 2006;
de La Fortelle & Bricogne, 1997) with data collected at the
peak of the Se absorption edge (0.979 A ˚ ). Eight of the nine
possible Se sites were located with SHELXD (Sheldrick,
2008). Phase reﬁnement was performed with SHARP (de La
Fortelle & Bricogne, 1997; Bricogne et al., 2003) and the
phases were further improved by solvent ﬂattening using
SOLOMON and DM (Abrahams & Leslie, 1996). Automatic
tracing using ARP/wARP (Perrakis et al., 2001) was used to
partially build the model and the remainder of the model was
built and reﬁned with the programs Coot (Emsley & Cowtan,
2004) and REFMAC, with the ﬁnal steps using TLS reﬁnement
(Murshudov et al., 1997).
The structure of the AMPPCP complex of MtFPGS was
solved by molecular replacement with Phaser (McCoy et al.,
2005) using the MtFPGS–ADP structure as the search model.
The structure was reﬁned and built with Coot and REFMAC,
using TLS reﬁnement in the ﬁnal steps. Reﬁnement statistics
for both structures are presented in Table 2. The quality of
each model was inspected using the program PROCHECK
(Laskowski et al., 1993). All ﬁgures were generated using
PyMOL (DeLano, 2002).
3. Results
3.1. Three-dimensional structure of MtFPGS
MtFPGS is folded into two distinct domains, an N-terminal
ATPase domain and a C-terminal Rossmann-fold domain,
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Table 1
Data-collection statistics.
Values in parentheses are for the highest resolution shell: 2.11–2.0 A ˚ for
MtFPGS–ADP and 2.42–2.3 A ˚ for MtFPGS–AMPPCP.
MtFPGS–ADP MtFPGS–AMPPCP
Maximum resolution (dmin)( A ˚ ) 2.0 2.3
Observed reﬂections 221039 150909
Unique reﬂections to dmin 32271 21320
Rmerge† (%) 8.6 (63.0) 9.5 (65.7)
I/ (I) 14.3 (2.8) 14.1 (2.9)
Completeness (%) 100 (100) 100 (100)
Multiplicity 6.8 (6.8) 7.1 (7.3)
Unit-cell parameters (A ˚ ) a = b = c = 112.4 a = b = c = 112.4
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the observed
intensity and hI(hkl)i is the mean intensity.
Table 2
Structure-reﬁnement statistics.
MtFPGS–
ADP
MtFPGS–
AMPPCP
Resolution range (A ˚ ) 39.0–2.0 50.3–2.3
Rwork/Rfree† (%) 15.7/19.0 17.6/22.3
Total atoms, protein 3241 3215
Total atoms, solvent 168 122
B factors, protein 42.9 41.0
B factors, solvent 42.2 40.7
R.m.s. deviation from ideality
Bonds (A ˚ ) 0.020 0.023
Angles ( ) 1.84 2.06
Ramachandran plot (nonglycine residues)
Residues in most favored regions (%) 97 97
Residues in disallowed regions (%) — —
† R =
P   jFoj kjFcj
   =
P
jFoj 100. Rfree was calculated with 5% of the reﬂections.which are joined by a ﬂexible linker (Fig. 2). The N-terminal
domain (residues 1–334) is folded around a central seven-
stranded twisted  -sheet with six parallel strands and one
antiparallel strand. This  -sheet is ﬂanked by six  -helices on
one side and three  -helices on the other. A small three-
stranded antiparallel  -sheet packs against the back of this
domain and forms an expanded open barrel with strands from
the central  -sheet. The C-terminal domain (residues 342–489)
comprises a central six-stranded twisted  -sheet, with ﬁve
parallel strands and a single antiparallel strand, bounded by
ﬁve  -helices.
The structures of the ADP and AMPPCP complexes of
MtFPGS superimpose very closely on each other, with a root-
mean-square difference (r.m.s.d.) of 0.35 A ˚ for 381 C
  posi-
tions. Both structures contain similar disordered regions which
are not included in the model. These include the ﬁrst 23
residues and residues from four mobile loops: the  1– 2 loop
(residues 40–46 missing), the  4– 5 loop (residues 144–148
missing), the  6– 6 loop (residue 227 missing) and the  12–
 16 loop (residues 458–464 missing) (Fig. 2). Of these loops,
only the  1– 2 loop appears to be functionally important,
having been shown to be involved in pteroate binding in
E. coli FPGS (Mathieu et al., 2005).
The relative orientations of the two domains of MtFPGS
correspond to the ‘activated’ conformation observed for the
folate complexes of E. coli FPGS (EcFPGS; PDB code 1w78;
Mathieu et al., 2005) and L. casei FPGS
(LcFPGS; PDB code 1jbw; Sun et al., 2001).
MtFPGS shares 27.5% and 31.5% sequence
identity, respectively, with these enzymes
and superposition with SSM (Krissinel &
Henrick, 2004) shows that the complete
MtFPGS molecule can be superimposed
onto their respective folate complexes with
r.m.s.d.s of 1.55 A ˚ for 381 C
  positions
(EcFPGS) and 1.67 A ˚ for 378 C
  positions
(LcFPGS). Corresponding values when
the individual domains of MtFPGS were
superimposed on the E. coli and L. casei
proteins were 1.60 A ˚ (255 C
 ) and 1.56 A ˚
(276 C
 ), respectively, for the N-terminal
domains and 1.27 A ˚ (120 C
 ) and 1.88 A ˚
(105 C
 ), respectively, for the C-terminal
domains.
Cobalt chloride was essential for the
crystallization of MtFPGS, and four bound
Co
2+ ions have been identiﬁed on the basis
of their density and associated anomalous
signal. Two of these cobalt ions are involved
in crystal contacts. One sits on the
crystallographic threefold axis, where it is
coordinated by two ligands (a water mole-
cule and Asp326 O
 1) from each of the three
symmetry-related molecules (Fig. 3a). The
other cobalt ion forms a bridge between the
side chains of Asp455 and Asp457 on helix
 12 of the C-terminal domain and is also
coordinated by His370 from helix  10 of the
C-terminal domain of an adjacent molecule
and by three water molecules (Fig. 3b). This
appears to anchor the end of helix  12,
which is signiﬁcantly longer in MtFPGS (17
residues) than in either EcFPGS or
LcFPGS, in which it is only ten residues in
length. The loop following this anchor point
is larger than in either E. coli or L. casei
FPGS and is disordered in MtFPGS. The
other two cobalt ions are associated with
residues in the active site and will be
discussed in more detail later.
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Figure 2
Ribbon diagram of MtFPGS in stereoview.The N-domain is shown in grey and the C-domain is
shown in light cyan. The P-loop is shown in red, the  5– 6 loop in dark blue and the
interdomain-connecting peptide in orange. Dashed lines represent sections of the polypeptide
chain lacking electron density, including the disordered DHP-binding loop ( 1– 2) and several
other mobile loops. The small three-stranded  -sheet is shown in teal and the bound ADP is
shown in magenta in stick mode. Co atoms are shown as dark blue spheres, with Co1 and Co2
showing the location of the cobalt ions involved in crystal contacts.
Figure 3
Coordination of cobalt ions involved in protein crystal contacts. (a) Co1, which is situated on
the crystal threefold axis and mediates contacts with Asp326 in the N-terminal domains of
three adjacent FPGS molecules. (b) Co2, which is coordinated between the C-terminal
domains of two adjacent protein molecules. Cobalt ions (Co) are represented as dark blue
spheres and water molecules are represented as red spheres.3.2. Nucleotide binding
Crystals of MtFPGS only grew in the presence of the
nucleotides ADP, AMPPNP or AMPPCP. Extensive efforts
were made to crystallize either apoprotein or folate
complexes, but to date these have been unsuccessful. In both
the ADP and AMPPCP structures the contacts between
protein and nucleotide are essentially the same (Table 3). The
nucleotide occupies a narrow channel between the N- and
C-terminal domains (Fig. 4), where it adopts the same ‘acti-
vated’ conformation as observed in EcFPGS (Mathieu et al.,
2005). The adenine ring sits in a deep pocket formed by the
glycine-rich P-loop (Gly73–Gly76), strand  5 and helix  8,
where it stacks between the P-loop and His299 and is
anchored by hydrogen bonding to Asn303, which is conserved
in all FPGS enzymes. The ribose moiety hydrogen bonds to a
conserved aspartate residue (Asp353) from strand  12. In the
ADP structure, Asn75 from the P-loop is closer to the ribose
moiety than in the AMPPCP complex and the E. coli or
L. casei structures and forms an additional hydrogen bond to
one of the ribose O atoms.
The  -phosphate of the nucleotide (both ADP and
AMPPCP) sits at the N-terminus of helix  3, in contact with
the main-chain N atoms of Gly76 and Ser79, the side-chain O
atom of Ser79 and the side chain of Arg340 from the linker
region between the N- and C-terminal domains. The  -phos-
phate is adjacent to the P-loop and is anchored by hydrogen
bonds to the peptide NH groups of Lys77 and Thr78, Lys77 N
 
and Thr78 O
 2 (Fig. 4). The  -phosphate group of the
AMPPCP points into the inter-domain cleft towards the
external solvent and is hydrogen bonded to the imidazole N
atom of His356 from the loop between  12 and  10,
Arg340 N
 1, Thr78 O
 2 and a water molecule.
3.3. Divalent-cation interactions
In both the EcFPGS and LcFPGS structures two magne-
sium ions are found in the active site, where they are believed
to play important functional roles. The ﬁrst is the ‘classical’
magnesium ion, which is associated with the  - and  -phos-
phates of ATP and which is common to the FPGS enzymes
and many related ATPases. In MtFPGS this is displaced by a
cobalt ion which has a similar, although not identical, coor-
dination. In the AMPPCP structure this cobalt ion is octa-
hedrally coordinated to two O atoms from the  - and  -
phosphate groups, the carbonyl O atom of Ser100 from the -
loop and the O
"1 atom of Glu176 from strand  4 (these four
atoms forming a plane), with a water molecule and Thr78 O
 2
in the axial positions (Fig. 4). In the ADP complex two waters
substitute for  -phosphate O atoms, with
one of them replacing the  -phosphate O
atom in the cobalt coordination sphere.
In most FPGS sequences, the residue
equivalent to Thr78 is a glycine (Smith et al.,
2006) and, as shown in the E. coli and
L. casei structures, this metal-coordination
site is occupied by a water molecule.
MtFPGS appears to be representative of a
subgroup comprising members of the order
Actinomycetales, which includes the Cory-
nebacteriaeae (Corynebacteria and Myco-
bacteria) and Streptomycineae suborders
and whose FPGS enzymes have a threonine
at this position and a consensus P-loop
sequence NGKTS. In this regard, the FPGS
enzymes from these bacterial species have a
P-loop that is more similar to purine
nucleotide triphosphatases (NTPases) such
research papers
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Table 3
Hydrogen-bond contacts between MtFPGS and bound nucleotides.
Water-mediated contacts are excluded.
MtFPGS–ADP MtFPGS–AMPPCP
Atom
Distance
(A ˚ ) Atom
Distance
(A ˚ )
Adenine-ring moiety
N6 Asn303 O
 1 2.95 Asn303 O
 1 3.10
N7 Asn303 N
 2 2.97 Asn303 N
 2 3.01
Ribose moiety
O2 Asp353 O
 1 2.85 Asp353 O
 2 2.88
O3 Asp353 O
 1 2.90 Asp353 O
 1 2.78
Asp353 O
 2 2.94 Asp353 O
 2 3.20
O4 Asn75 N
 2 3.16
 -Phosphate
O1A Arg340 N
" 2.84 Arg340 N
" 2.69
Arg340 N
 2 2.80 Arg340 N
 2 3.07
O2A Ser79 N 2.99 Ser79 N 3.27
Ser79 O
  2.78 Ser79 O
  2.78
O3A Gly76 N 2.94 Gly76 N 2.90
 -Phosphate
O1B Thr78 N 2.71 Thr78 N 2.82
Thr78 O
 1 3.03 Thr78 O
 1 3.30
Co2 2.02 Co2 2.13
O2B Lys77 N 2.80 Lys77 N 3.02
Lys77 N
  2.79 Lys77 N
  2.64
 -Phosphate
O1G His356 N
"2 3.07
O2G Arg340 N
 2 3.17
Thr78 O
 1 3.14
Co2 1.97
Figure 4
Stereoview showing the contacts made between AMPPCP and MtFPGS. AMPPCP is shown in
stick mode, coloured by atom type. The active-site cobalt ion is represented as a dark blue
sphere and water as a red sphere. Broken lines represent contacts that have the appropriate
geometry (distances and angles) and partners to represent hydrogen bonds.as ras P21, the G proteins and other ATP-dependent amide-
bond ligases such as the mur family of bacterial cell-wall
ligases. All of these enzymes have a hydroxyl residue (serine
or threonine) at this position, the side chain of which forms
part of the classical magnesium ion-binding site (Smith &
Rayment, 1996; Smith, 2006).
The second Mg atom (Mg2) found in other FPGS structures
is bound to a conserved histidine in the active site, His173 in
EcFPGS or His170 in LcFPGS (His203 in MtFPGS), and is
linked via two water ligands to a conserved carbamylated
lysine (Lys218 in MtFPGS), as discussed later. Mg2 is rather
variably positioned in different FPGS complexes, but an
equivalent magnesium ion is also found in some of the mur
ligases. It is believed that this magnesium may be important
for counterbalancing the negative charge of the  -phosphate
and the incoming carboxylate group and further stabilizing the
acyl-phosphate intermediate (Sun et al., 2001).
In both the ADP and AMPPCP complexes of MtFPGS a
cobalt ion is bound to the equivalent histidine, His203, as well
as Asp205 and two waters (Fig. 5a). There is a major differ-
ence in comparison with the other FPGS structures, however,
in that in MtFPGS the  5– 6 loop (residues 197–210), to
which His203 belongs, undergoes a conformational change
that ﬂips His203 out of the active site. This movement, toge-
ther with the changed carbamylation status of Lys218, appears
to be part of a coordinated series of changes that regulate
activity.
3.4. Carbamylation of Lys218
A common feature of both the EcFPGS and LcFPGS
structures and of the majority of the mur ligase superfamily is
the presence of a carbamylated lysine (Lys188 in EcFPGS,
Lys185 in LcFPGS). In most structures it is a second-shell
ligand of the second magnesium ion, Mg2, hydrogen-bonded
to two of the waters in the coordination sphere of Mg2. In the
MtFPGS structures, however, the equivalent residue, Lys218,
is not carbamylated. This is also true of both T. maritima
FPGS (PDB code 1o5z) and the apo structures of LcFPGS
(1fgs, 2gca). Analysis of the crystallization conditions of all
FPGS and mur ligase enzymes shows a correlation between
the pH of crystallization and the presence of a carbamylated
lysine. In all structures crystallized at pH 7 and above, with the
singular exception of MurF (1gg4), the equivalent lysine is
carbamylated, whereas in those structures crystallized below
pH 7 it remains unmodiﬁed.
Similar pH-dependent carbamylation of lysine has been
previously documented with the class D OXA-10  -lacta-
mases, which depend on a carbamylated lysine for the
hydrolysis of  -lactam moieties. Crystal structures of this
enzyme show a clear correlation between the pH of the
crystallization buffer and the degree of carbamylation, with an
increase in carbamylation of speciﬁc lysine residues from pH
6.0 through to full carbamylation of these residues at pH 8.5
(Golemi et al., 2001). The carbamylation of lysine in FPGS
enzymes may explain the nonspeciﬁc activation of FPGS by
sodium bicarbonate (Bolanowska et al., 1990) and also the
effect of pH on the activity of FPGS; little activity is observed
below pH 7.5 (Shane, 1980).
3.5. Loop movement in MtFPGS
A signiﬁcant difference between the two MtFPGS struc-
tures and the structures of other FPGS enzymes is found in the
loop connecting strand  5 to helix  6 (residues 197–210). This
loop is a key part of the active site, as it includes the histidine
that binds Mg2 (His203 in MtFPGS) and an aromatic residue
(Trp176 in EcFPGS) which helps form the pocket that binds
the pterin ring of folate in EcFPGS. It also mediates important
contacts between the C-terminal domain and the pterin-
binding pocket in the N-terminal domain.
In the majority of FPGS structures, the  5– 6 loop forms a
single-turn helix ( 5b in EcFPGS) and
packs tightly against the N-terminal domain.
However, in MtFPGS this loop has moved
away from the N-terminal domain and
adopts an ‘open’ conformation stabilized by
hydrogen-bonding interactions with the
loop between strand  13 and helix  11,
involving residues Val204–Asp386, His203–
Asp386, Asp202–Lys387 and Ile201–Asn357
(Fig. 5a). In both T. maritima FPGS (1o5z)
and the L. casei MgATP complex (1fgs) the
 5– 6 loop is disordered, which suggests
that it may be moving between an ‘open’
state, represented by the MtFPGS struc-
tures, and a ‘closed’ state characteristic of
the EcFPGS structures and the folate-bound
LcFPGS structure (Fig. 6). In MtFPGS a
glycerol molecule occupies the cavity left
open by the movement of the  5– 6 loop
and is hydrogen-bonded to Lys218 N
 ,
Thr74 O
 2, the carbonyl O atom of His203,
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Figure 5
Ribbon diagrams showing bonding-stabilizing interactions involving loop  5– 6 (residues 197–
210) in its ‘open’ conformation. (a)AC o
2+ ion (Co4, shown as a dark blue sphere) is bound by
His203 and Asp205; residues 201–204 also participate in a hydrogen-bond network with
residues 357 and 386–387 from the C-terminal domain. (b) Hydrogen-bond interactions
between glycerol and residues lining the cavity created by the movement of loop  5– 6i n
MtFPGS. Water molecules are shown as red spheres.the amide N atoms of Asp202 and His203 and a water mole-
cule (Fig. 5b).
4. Discussion
Polyglutamylation of folate substrates by FPGS is believed to
follow a ter-ter sequential mechanism in which MgATP binds
ﬁrst, folate second and glutamate last (Shane, 1980). The
structure of MtFPGS is entirely consistent with this
mechanism and, together with the previously determined
structures of EcFPGS (Mathieu et al., 2005) and LcFPGS (Sun
et al., 1998, 2001) and modelling studies (Tan & Carlson, 2005),
points to some of the conformational changes along the
reaction pathway.
The ADP and AMPPCP complexes of MtFPGS show that
these structures represent the ‘activated’ conformation in
which the enzyme is prepared for folate binding; the adenine
and ribose rings are fully buried, with only the triphosphate
moiety exposed to the incoming folate. At least two different
folate-binding sites have been observed in FPGS: that iden-
tiﬁed in EcFPGS, which is believed to be associated with
DHFS activity (Mathieu et al., 2005), and a second observed in
LcFPGS, which may be used as the polyglutamate tail
lengthens (Sun et al., 2001; Tan & Carlson, 2005). These clearly
map to a long surface groove in MtFPGS (Fig. 7). While both
sites appear to be fully accessible, we were not able to prepare
folate complexes of MtFPGS either by cocrystallization or by
soaking. This suggests that binding of substrate to MtFPGS
requires a conformational change which
cannot be accommodated in the current
crystal form or that the crystal pH (5.5) is
not favourable for binding or both. FPGS is
inactive at the crystal pH, having little
activity below pH 7.5 (Shane, 1980), but all
attempts to grow crystals above pH 5.5 or
soak crystals at higher pH were unsuc-
cessful. While the  5– 6 loop does make
crystal contacts in the MtFPGS structure,
which may restrain its movement, we further
suggest that the noncarbamylation of Lys218
at the crystal pH may also contribute to the
failure to prepare stable folate complexes, as
discussed below.
Folate binding in EcFPGS is associated
with the closure of a loop (residues 25–32)
over the pteridine ring to generate a narrow
pocket (Mathieu et al., 2005). This loop is
referred to as the dihydropteroate (DHP)
binding loop. Deletion of this loop in an
N-terminal deletion mutant of EcFPGS
severely reduces but does not completely
abolish activity (Kimlova et al., 1991), indi-
cating its functional importance. In the
MtFPGS structures, the equivalent loop
(residues 42–49) is in an open conformation
and is partially disordered (Fig. 6a). The
disordered region includes residues Ile45
and Pro47, which correspond to E. coli
residues Ile28 and Leu30, which stack
against the pterin ring. In E. coli these
hydrophobic residues are stabilized by their
interactions with Trp176 on helix  5b
(Mathieu et al., 2005). In MtFPGS the
corresponding stabilizing residue (Tyr206)
has moved 11 A ˚ away as the single-turn
helix  5b unwinds in the ‘open’ form of the
 5– 6 loop (Fig. 6b).
The accepted mechanism for the forma-
tion of a new amide bond in the DHFS and
FPGS enzymes begins with the ATP-
dependent activation of the free carboxylate
research papers
Acta Cryst. (2008). D64, 745–753 Young et al.   Folylpolyglutamate synthase 751
Figure 6
The DHP-binding loop and its environment. (a) Electron density (from an Fo   Fc OMIT map
contoured at 1.5 ) for the DHP-binding loop of MtFPGS (residues 36–50). No interpretable
density is found between Arg39 and Asp46. The positions of these latter residues suggest that
the loop has a different conformation from that of EcFPGS, which is shown as a green ribbon.
(b) Stereoview showing changes in the DHP-binding loop and the  5– 6 loop in the MtFPGS
(teal) and EcFPGS (green) structures. Residues Arg39 and Asp46, which ﬂank the disordered
part of the DHP-binding loop in MtFPGS, are circled. The E. coli DHP-binding loop, in
contrast, is ordered and is closed over the substrate. DHP binding in EcFPGS leads to the
‘closing’ of the DHP-binding loop from an ‘open’ position similar to that seen in MtFPGS. The
‘closed’ position is stabilized by hydrophobic interactions involving Ile28 and Leu30 from the
DHP-binding loop and Trp176 from the  5– 6 loop. In MtFPGS, the open  5– 6 loop causes
Tyr206, corresponding to Trp176 in EcFPGS, to move 11 A ˚ away. Other accompanying changes
in MtFPGS compared with EcFPGS are the rotation of His203 away from the Mg2-binding
site, the loss of this magnesium ion and the noncarbamylation of Lys218. In the EcFPGS
structure, phosphorylated DHP (DHPP), Mg2 (green sphere), its water ligands (red spheres)
and the carbamylated Lys188, which forms part of the second-shell coordination of Mg2, can
all be observed. ADP is situated below the DHPP and is identically positioned in MtFPGS and
EcFPGS.group on DHP or the folate substrate. Since this requires the
close approach of the negatively charged  -phosphate and
carboxylate groups, a divalent cation is necessary to counter
some of the negative charge and thus facilitate acyl-phosphate
formation (Sun et al., 2001). This cation, typically magnesium
(Mg2), is found in both the FPGS enzymes and the related
mur ligases (Smith, 2006), albeit with some variation in its
binding site. The mobility of this metal ion may be essential to
its role in stabilizing the charges in the active site.
The MtFPGS structures presented here suggest that the
highly mobile  5– 6 loop may provide a mechanistic switch
linking the coordination of Mg2 with DHP binding through
stabilization of the DHP-binding loop. In EcFPGS the  5– 6
loop (which contains the  5b helix) is involved in Mg2 co-
ordination through His173 and with stabilization of the DHP-
binding loop through Trp176. This is also likely to be the case
in MtFPGS, as EcFPGS and MtFPGS have both been shown
to have FPGS and DHFS activity (A. Bognar, personal
communication). However, in MtFPGS the ‘open’ conforma-
tion of the  5– 6 loop results in both residues (His203 and
Tyr206) being ﬂipped away.
The carbamylation of the conserved lysine (Lys218 in
MtFPGS) also appears to be essential for the stabilization of
Mg2 in FPGS enzymes and mur ligases. When there is no
carbamylation of this lysine, no Mg2 is associated with the
histidine (His203 in MtFPGS) and the  5– 6 loop is either
disordered or has substantially shifted. We propose that there
is a synergistic relationship between lysine carbamylation,
Mg2 binding and the movement of the  5– 6 loop and thence
the DHP-binding loop which helps regulate the DHFS activity
of these enzymes.
A possible mechanistic sequence for DHFS activity in
MtFPGS would see ATP binding ﬁrst, with the concomitant
binding of Mg1 and Mg2 and the closure of the  5– 6 loop
from an ‘open’ state as seen in MtFPGS to a ‘closed activated’
state as seen in EcFPGS. This in turn stabilizes the DHP loop
through hydrophobic stacking interactions mediated by
Tyr206 and facilitates stable binding of the DHP substrate.
There is evidence from mutagenesis and binding studies that
this site, formed by closure of the DHP loop, accommodates
both DHP and monoglutamylated folate derivatives (Sheng et
al., 2008) and thus supports the DHFS reaction and the ﬁrst
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Figure 7
Surface representation of MtFPGS (a) and EcFPGS (b), showing the DHP-binding site, with DHPP from the EcFPGS structure modelled into the
MtFPGS structure. The N- and C-terminal domains of MtFPGS are coloured teal and light teal, respectively, and those of EcFPGS green and light green,
respectively. The  5– 6 loop is coloured red and moves from an ‘open’ state as in MtFPGS to a closed state as in EcFPGS, where it stabilizes the closed
conformation of the DHP-binding loop (blue), forming a deep narrow pocket around DHPP. Without the stabilizing interaction of a closed  5– 6 loop,
the DHP-binding loop in MtFPGS is mobile and a disordered region joins the two ends (shown in blue). An open cavity is exposed, allowing ready
binding or dissociation of DHP or DHF. The nucleotide is almost fully buried in each protein, with only its  -phosphate seen, pointing into the inter-
domain cleft towards the phosphate group on DHPP. To the right of the DHPP a long groove (indicated by a curved solid black line) extends around to
the back of the protein. This is thought to be the cleft associated with successive additions of glutamate residues and contains 5,10-methylene-
tetrahydrofolate in the LcFPGS structure.FPGS glutamylation. Diglutamylated and polyglutamylated
derivatives, in contrast, are likely to use the extended cleft
shown in Fig. 7, as in the LcFPGS–folate structure, thus
explaining how the enzyme accommodates the growing sub-
strate during successive additions of glutamate residues. The
number of residues added by the FPGS of a particular
organism may then depend on the length of this cleft.
The structural results presented here on the MtFPGS
enzyme have allowed some insight into the mode by which this
enzyme could be activated and the means by which substrate
binding and the presence of the product are communicated
throughout the active site. It also adds to the growing under-
standing of how the growing polyglutamate tail is accom-
modated by the enzyme. Finally, the structural and molecular
features presented by FPGS suggest considerable potential for
drug design. Many potent inhibitors are available that target
ATP-binding sites, for example in kinases, and have appro-
priate pharmacokinetic properties for drug development.
These could provide leads directed at the highly conserved
nucleotide-binding site in FPGS, with further selectivity and
afﬁnity being added by the elaboration of such compounds to
exploit the nearby DHP pocket and surface groove on FPGS.
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